prostatitis
PROSTATITIS

Prostatitis is the inflammation of the prostate that may be caused by infection, chronic pelvic pain syndrome or asymptomatic prostate inflammation.

Prominent features are genitourinary, pelvic or rectal pain and lower urinary tract symptoms, eg urinary frequency, urgency, hesitancy, weak stream and straining on urination, dysuria, pain that increased with urination.

Follow Up

  • Persistent prostatitis may be managed by another course of antibiotic therapy adjusted according to susceptibility results; course is more prolonged & consists of a higher dosage or different agent
  • Consider referral to a specialist for evaluation if patient is unresponsive to modified antibiotic therapy or if w/ severe symptoms
Acute Bacterial Prostatitis (ABP)
  • Assess clinical response on follow-up along with a urine culture collected 7 days after antibiotic therapy
  • Suspect a prostatic abscess if patient failed to improve with antibiotic therapy
  • Complications of acute bacterial prostatitis (ABP) include acute urinary retention, prostatic abscess, chronic bacterial prostatitis, fistula formation, sepsis, or spread of infection to spine or sacroiliac joints
Chronic Bacterial Prostatitis & Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CBP & CP/CPPS)
  • May use the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) & InternationalProstate Symptom Score (IPSS) as validated tools for determining improvement of patient’s symptoms or quality of life w/ time or treatment
    • A 6-point decrease from baseline in the total score of National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) is the threshold for prediction of response to treatment
  • Patients refractory to treatment may be given the following:
    • Psychosocial screening, eg history of trauma including emotional, physical, or sexual abuse, for possible referral to mental health services
    • Consider giving phytotherapy, eg bioflavonoids, pollen extracts, &/or saw palmetto, as a treatment option
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 3 days ago

Patients with mild hypertension who are at low risk for cardiovascular disease (CVD) do not appear to derive mortality or CVD benefit from antihypertensive treatments, raising questions on the need for treatment in this population, according to a recent study from England.

Pearl Toh, 6 days ago
A personalized computerized neurofeedback intervention for training attention and memory shows potential in cognitive training for healthy elderly men, who improved in cognitive performance after the training, although no significant improvements were seen in the overall study population.
4 days ago
The simple Atrial fibrillation (AF) Better Care (ABC) pathway holistically updates the integrated care for AF patients and helps reduce the risk of adverse outcomes such as all-cause mortality, stroke/major bleeding/cardiovascular death and hospitalization, according to a study.
Yesterday
Type 1 diabetes impairs cognitive functioning in children, and this effect is exacerbated by extreme glycaemic levels, according to a recent meta-analysis.